Author

Noriaki Kataoka

Observed names: KATAOKA, NORIAKI, N. Kataoka, NORIAKI KATAOKA, 片岡, 憲昭

Institution: Osaka Medical and Pharmaceutical University Hospital

Observed institutions: Osaka Medical and Pharmaceutical University Hospital, Kindai University

ORCID: 0000-0002-8425-9364

Observed ORCID: 0000-0002-8425-9364

OpenAlex ID: A5020120291

A Case of Bronchiolitis Obliterans Organizing Pneumonia Associated with Primary Sjögren’s Syndrome Who Died of Superimposed Diffuse Alveolar Damage

2009 · Y. Usui, Y. Kimula, et al. · Respiration · 29

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

2023 · Satoshi Dote, Eiji Shiwaku, et al. · International Journal of Clinical Oncology · 9

Predictors of abemaciclib discontinuation in patients with breast cancer: a multicenter retrospective cohort study

2024 · Noriaki Kataoka, Takeo Hata, et al. · BMC Cancer · 4

[Serotonin syndrome in a patient with small cell lung cancer].

2013 · Chieko Takahashi, Emi Goto, et al. · PubMed · 3

Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study

2024 · Noriaki Kataoka, Takeo Hata, et al. · Journal of Chemotherapy · 1

Platelet count and dose, but not comorbidities, predict severe neutropenia in cabazitaxel-treated prostate cancer patients: A retrospective observational study

2023 · Noriaki Kataoka, Takeo Hata, et al. · International Journal of Clinical Pharmacology and Therapeutics · 1

Predictors of Discontinuation of Eribulin Therapy for Metastatic Breast Cancer: A Retrospective Cohort Study

2026 · CHIEKO HATA, TAKEO HATA, et al. · Anticancer Research

実臨床データを用いた抗がん剤治療の安全性に関する後方視的研究

2025 · KATAOKA, NORIAKI · Institutional Repositories DataBase (IRDB)

実臨床データを用いた抗がん剤治療の安全性に関する後方視的研究

2024 · 片岡, 憲昭 · Institutional Repositories DataBase (IRDB)

Works count: 9

Citation count: 47

H-index: 3

I10-index: 1